NL6615028A - - Google Patents

Info

Publication number
NL6615028A
NL6615028A NL6615028A NL6615028A NL6615028A NL 6615028 A NL6615028 A NL 6615028A NL 6615028 A NL6615028 A NL 6615028A NL 6615028 A NL6615028 A NL 6615028A NL 6615028 A NL6615028 A NL 6615028A
Authority
NL
Netherlands
Application number
NL6615028A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6615028A publication Critical patent/NL6615028A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL6615028A 1965-10-23 1966-10-24 NL6615028A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00504087A US3821387A (en) 1965-10-23 1965-10-23 The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles
US55687966A 1966-06-13 1966-06-13

Publications (1)

Publication Number Publication Date
NL6615028A true NL6615028A (en:Method) 1967-04-24

Family

ID=27054718

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6615028A NL6615028A (en:Method) 1965-10-23 1966-10-24

Country Status (7)

Country Link
US (2) US3821387A (en:Method)
CH (1) CH505824A (en:Method)
DE (1) DE1620224A1 (en:Method)
FR (2) FR1602626A (en:Method)
GB (2) GB1167563A (en:Method)
NL (1) NL6615028A (en:Method)
SE (1) SE312556B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912746A (en) * 1970-08-28 1975-10-14 American Cyanamid Co Substituted nitrogen containing heteroethyleneindoles
US4160862A (en) * 1972-06-12 1979-07-10 Sterling Drug Inc. 1-Acyl-3-(amino-lower-alkyl)indoles
US4031221A (en) * 1974-06-17 1977-06-21 American Hoechst Corporation Method of treating pain and hypertension
US4242347A (en) * 1979-06-18 1980-12-30 Ciba-Geigy Corporation Hypotensive indolylalkylpiperidyl guanidines and isoureas
US4327103A (en) * 1980-07-07 1982-04-27 Hoechst-Roussel Pharmaceuticals Incorporated 3-{3-[4-(4-Fluorobenzoyl)piperidyl]propyl}-2-methyl indole
US4861880A (en) * 1982-09-20 1989-08-29 Pfizer Inc. 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4977178A (en) * 1982-09-20 1990-12-11 Pfizer Inc. Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents
DE3308668A1 (de) * 1983-03-11 1984-09-13 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
EP0187122A3 (de) * 1985-01-03 1987-12-16 Ciba-Geigy Ag 1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine
US5274097A (en) * 1988-04-19 1993-12-28 Bayer Aktiengesellschaft 1,3-disubstituted pyrrolidines
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds
TW472045B (en) * 1996-09-25 2002-01-11 Astra Ab Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation
AR017200A1 (es) 1997-12-23 2001-08-22 Astrazeneca Ab Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos
SE9800835D0 (sv) 1998-03-13 1998-03-13 Astra Ab New Compounds
CN1234705C (zh) * 1998-04-28 2006-01-04 埃尔比昂股份公司 新的羟基吲哚、其作为磷酸二酯酶4抑制剂的应用及其制备方法
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
US6346625B1 (en) 1999-06-23 2002-02-12 Astrazeneca Ab Protein kinase inhibitors
JP6533514B2 (ja) * 2013-03-27 2019-06-19 ビーブ・ヘルスケア・ユーケイ・(ナンバー5)・リミテッドViiV Healthcare UK (No.5) Limited Hiv結合阻害剤としての2−ケトアミド誘導体

Also Published As

Publication number Publication date
CH505824A (de) 1971-04-15
FR1602626A (en:Method) 1971-01-04
DE1620224A1 (de) 1970-02-12
US3642803A (en) 1972-02-15
GB1167562A (en) 1969-10-15
SE312556B (en:Method) 1969-07-21
FR6253M (en:Method) 1968-08-19
US3821387A (en) 1974-06-28
GB1167563A (en) 1969-10-15

Similar Documents

Publication Publication Date Title
FR1602626A (en:Method)
BE662702A (en:Method)
JPS4513740Y1 (en:Method)
JPS4417854Y1 (en:Method)
JPS4317811Y1 (en:Method)
JPS4427306Y1 (en:Method)
JPS449969Y1 (en:Method)
JPS4730720Y1 (en:Method)
JPS456664Y1 (en:Method)
BE660144A (en:Method)
BE674935A (en:Method)
NL130998C (en:Method)
NL6514537A (en:Method)
BE686874A (en:Method)
BE682081A (en:Method)
AU3532465A (en:Method)
BE675071A (en:Method)
BE675057A (en:Method)
BE587510A (en:Method)
BE675035A (en:Method)
BE675028A (en:Method)
BE657982A (en:Method)
BE671964A (en:Method)
BE660387A (en:Method)
BE660885A (en:Method)